Published in Br J Clin Pharmacol on October 01, 2005
Time-dependent Amiodarone Treatment in Atrial Fibrillation | NCT03432663
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Update on anti-coagulation in atrial fibrillation. QJM (2011) 1.28
Rate versus rhythm control in atrial fibrillation. Can Fam Physician (2013) 0.86
Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation. J Stroke (2013) 0.77
Atrial fibrillation (chronic). BMJ Clin Evid (2008) 0.75
Rate versus rhythm in atrial fibrillation: and how slow do you go? Can Fam Physician (2011) 0.75
Current Evidence and Recommendations for Rate Control in Atrial Fibrillation. Arrhythm Electrophysiol Rev (2013) 0.75
One hundred years of atrial fibrillation. Br J Clin Pharmacol (2005) 0.75
Atrial fibrillation (chronic). BMJ Clin Evid (2011) 0.75
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Confidence intervals for the number needed to treat. BMJ (1998) 9.59
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med (1999) 7.74
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med (1997) 5.25
Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet (2000) 3.36
Gauging the impact of statins using number needed to treat. JAMA (1999) 2.89
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol (2003) 2.73
Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol (2003) 2.20
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med (2003) 1.65
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study. Eur Heart J (2004) 1.54
Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med (2004) 1.52
Rate or rhythm control in persistent atrial fibrillation? QJM (2003) 1.47
Rest heart rate and life expectancy. J Am Coll Cardiol (1997) 1.39
Antithrombotic therapy in atrial fibrillation. Chest (1998) 1.38
Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm control. BMJ (2003) 1.11
New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. Drugs (2002) 1.00
New insights into the mechanisms and management of atrial fibrillation. CMAJ (2002) 0.96
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart (2002) 0.95
Long-term management of atrial fibrillation: rhythm or rate control? CMAJ (2003) 0.95
To be or not to be in normal sinus rhythm: what do we really know? Ann Intern Med (2004) 0.88
Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study. Kardiol Pol (2003) 0.87
Rhythm versus rate control for atrial fibrillation management: what recent randomized clinical trials allow us to affirm. CMAJ (2003) 0.86
Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med (1996) 0.81
Risks and benefits of rate control versus maintenance of sinus rhythm. Am J Cardiol (2003) 0.81
The burden of rate control in atrial fibrillation. J Cardiovasc Pharmacol Ther (2003) 0.78
Management of atrial fibrillation--radical reform or modest modification? N Engl J Med (2002) 0.78
Does sinus rhythm beget sinus rhythm? Effects of prompt cardioversion on the frequency and persistence of recurrent atrial fibrillation. Card Electrophysiol Rev (2003) 0.78
Atrial fibrillation: rate control often better than rhythm control. Prescrire Int (2004) 0.77
Rhythm or rate control in atrial fibrillation: insights from the randomized controlled trials. J Cardiovasc Pharmacol Ther (2003) 0.77
Concise review of atrial fibrillation: treatment update considerations in light of AFFIRM and RACE. Clin Cardiol (2004) 0.77
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension (2006) 11.68
Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol (2008) 2.63
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation (2007) 2.29
Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension (2007) 2.23
Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care (2007) 1.88
Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008. Atherosclerosis (2011) 1.50
Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension (2008) 1.49
A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences. Chest (2004) 1.46
Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol (2004) 1.44
Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis (2012) 1.39
Obesity susceptibility genetic variants identified from recent genome-wide association studies: implications in a chinese population. J Clin Endocrinol Metab (2010) 1.29
The effect of health-related quality of life (HRQOL) on health service utilisation of a Chinese population. Soc Sci Med (2002) 1.29
Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab (2011) 1.25
Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol (2010) 1.17
Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology (2004) 1.15
Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens (2007) 1.14
High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects. Diabetes Care (2011) 1.10
Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf) (2007) 1.09
The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Rev Clin Pharmacol (2012) 1.08
Pharmacotherapy for obesity. Br J Clin Pharmacol (2009) 1.08
Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2013) 1.08
Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005-2006. Clin Chem Lab Med (2010) 1.03
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Ann Epidemiol (2012) 1.01
Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. Obesity (Silver Spring) (2010) 0.97
Using glycosylated hemoglobin to define the metabolic syndrome in United States adults. Diabetes Care (2010) 0.96
The pharmacogenetics of the response to warfarin in Chinese. Br J Clin Pharmacol (2012) 0.95
Correlation of large artery intracranial occlusive disease with carotid intima-media thickness and presence of carotid plaque. Stroke (2012) 0.94
Utilization of lipid lowering medications among adults in the United States 1999-2006. Atherosclerosis (2009) 0.91
Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men. J Alzheimers Dis (2010) 0.91
Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance. Peptides (2006) 0.90
Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc Dis (2012) 0.90
Genetic variants associated with persistent central obesity and the metabolic syndrome in a 12-year longitudinal study. Eur J Endocrinol (2010) 0.89
Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study. J Clin Endocrinol Metab (2010) 0.89
The role of urotensin II in the metabolic syndrome. Peptides (2007) 0.89
Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes. J Card Fail (2003) 0.89
Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens (2009) 0.89
The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome. J Cardiovasc Pharmacol (2005) 0.88
High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults. Clin Nutr (2012) 0.88
Treatment and control of diabetes mellitus in the United States National Health and Nutrition Examination Survey, 1999-2002. J Cardiometab Syndr (2006) 0.88
Screening for fever by remote-sensing infrared thermographic camera. J Travel Med (2004) 0.87
Association of a polymorphism in the lipin 1 gene with systolic blood pressure in men. Am J Hypertens (2008) 0.87
Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction. PLoS One (2012) 0.87
Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese. Clin Endocrinol (Oxf) (2011) 0.86
Trends in C-reactive protein levels in US adults from 1999 to 2010. Am J Epidemiol (2013) 0.85
Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf) (2007) 0.85
A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes. Curr Diabetes Rev (2010) 0.85
A polymorphism in transforming growth factor-β1 is associated with carotid plaques and increased carotid intima-media thickness in older Chinese men: the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort. Atherosclerosis (2010) 0.85
Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin Endocrinol (Oxf) (2006) 0.84
Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA. BMC Med (2014) 0.84
Late-life body mass index and waist circumference in amnestic mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2009) 0.83
The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis. Curr Eye Res (2008) 0.83
Urotensin II: its function in health and its role in disease. Cardiovasc Drugs Ther (2005) 0.83
The decrement in circulating endothelial progenitor cells (EPCs) in type 2 diabetes is independent of the severity of the hypoadiponectemia. Diabetes Metab Res Rev (2011) 0.83
Serum beta-2 microglobulin concentration predicts cardiovascular and all-cause mortality. Int J Cardiol (2013) 0.82
Serum β-2 microglobulin predicts mortality in people with diabetes. Eur J Endocrinol (2013) 0.82
A genetic variant in the gene encoding adrenomedullin predicts the development of dysglycemia over 6.4 years in Chinese. Clin Chim Acta (2010) 0.82
The KCNJ11 E23K polymorphism and progression of glycaemia in Southern Chinese: a long-term prospective study. PLoS One (2011) 0.81
Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008. Ann Epidemiol (2012) 0.81
A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese. Eur J Hum Genet (2010) 0.81
Traveler's thrombosis: a systematic review. J Travel Med (2005) 0.81
Health promotion in older Chinese: a 12-month cluster randomized controlled trial of pedometry and "peer support". Med Sci Sports Exerc (2012) 0.81
A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am J Med Genet B Neuropsychiatr Genet (2007) 0.80
Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin. Postgrad Med (2011) 0.80
Is human cytomegalovirus infection associated with hypertension? The United States National Health and Nutrition Examination Survey 1999-2002. PLoS One (2012) 0.80
A single nucleotide polymorphism of interleukin-6 gene is related to plasma adrenomedullin levels. Clin Endocrinol (Oxf) (2013) 0.79
Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study. Metab Syndr Relat Disord (2014) 0.79
Reduced serum beta-trace protein is associated with metabolic syndrome. Atherosclerosis (2013) 0.79
Plasma level of adrenomedullin is influenced by a single nucleotide polymorphism in the adiponectin gene. PLoS One (2013) 0.79
Haemoglobin A1c is superior to fasting glucose in predicting the incidence of diabetes over 8 years among Chinese. Diabetes Res Clin Pract (2010) 0.79
Plasma concentration of pigment epithelium-derived factor is closely associated with blood pressure and predicts incident hypertension in Chinese: a 10-year prospective study. Clin Endocrinol (Oxf) (2012) 0.79
Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence. J Hypertens (2015) 0.79
Effectiveness of lipid lowering drugs in general practice: study had two major flaws. BMJ (2003) 0.78
Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo. Clin Exp Pharmacol Physiol (2005) 0.78
Pharmacogenetics of allopurinol--making an old drug safer. J Clin Pharmacol (2013) 0.78
Hyperglycaemia and vitamin D: a systematic overview. Curr Diabetes Rev (2012) 0.78
Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese. Thromb Haemost (2016) 0.77
Association between metabolic syndrome and carotid atherosclerosis: a community-based study in Hong Kong. Metab Syndr Relat Disord (2013) 0.77
Overview of dietary influences on atherosclerotic vascular disease: epidemiology and prevention. Cardiovasc Hematol Disord Drug Targets (2007) 0.77
Role of genetic variants in the gene encoding lipocalin-2 in the development of elevated blood pressure. Clin Exp Hypertens (2011) 0.77
Junctional adhesion molecule-1 may have a wider role in cardiovascular disease. Hypertension (2007) 0.77
Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study. Eur J Endocrinol (2006) 0.77
Hay fever and hypertension in the US adult population. Clin Exp Hypertens (2013) 0.77
Adrenomedullin gene expression and levels in the cardiovascular system after treatment with lipopolysaccharide. Neuropeptides (2004) 0.76
Thrombolysis for ischaemic stroke. Clin Med (2008) 0.75
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin. Br J Clin Pharmacol (2003) 0.75
Increase in adrenomedullin gene expression in the left atrium and ventricle in the two-kidney one-clip renovascular hypertensive rats. Neuropeptides (2003) 0.75
A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men. Thromb Haemost (2010) 0.75
Hypertension: a weighty problem in children. Postgrad Med J (2017) 0.75
Polymorphisms of the fibrinogen-beta gene are related to 2-hour glucose level after oral glucose tolerance test in Hong Kong Chinese. Dis Markers (2008) 0.75
Risk of stroke due to spontaneous cervical artery dissection. Intern Med (2012) 0.75
Loading doses for costly cancer biologicals: sound pharmacology or unnecessary extravagance? Eur J Cancer (2008) 0.75
Utility of infrared thermography for screening febrile subjects. Hong Kong Med J (2013) 0.75
Evolution of the Postgraduate Medical Journal. Postgrad Med J (2015) 0.75
Fake peer review - too good to be true. Postgrad Med J (2017) 0.75
Vascular protective effects of statin-related increase in serum 25-hydroxyvitamin D among high-risk cardiac patients. J Cardiovasc Med (Hagerstown) (2015) 0.75
The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. J Clin Endocrinol Metab (2013) 0.75
The effectiveness of a 'Do Not Use' list and perceptions of healthcare professionals on error-prone abbreviations. Int J Clin Pharm (2014) 0.75